| The effectiveness of oracin in enhancing the cytotoxicity of doxorubicin through the inhibition of doxorubicin deactivation in breast cancer MCF7 cells. | |
| | |
MedLine Citation:
|
PMID: 20698750 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The maximal therapeutic doses of the cytostatic drug doxorubicin (DOX) are strictly limited by the development of systemic toxicity, especially cardiotoxicity. The inhibition of DOX-metabolizing enzymes within cancer cells is possible strategy to improve DOX efficacy. In breast cancer cells (MCF7), DOX is effectively deactivated by carbonyl reduction. The aim of the present study was to test whether isoquinoline derivative oracin (ORC) is able to inhibit DOX reductases and to enhance DOX cytotoxic efficacy. The kinetics studies of DOX reduction in MCF7 cytosolic fractions were evaluated using high-performance liquid chromatography. The cytotoxicity of DOX, ORC, and DOX+ORC combinations was assayed using cell-viability tests and caspases activities and monitored using xCELLigence System for real-time cell analysis. ORC significantly inhibited DOX reduction in MCF7 cytosol. Competitive inhibition was found. The viability was significantly lower in cells treated with ORC+DOX combinations in comparison to cells treated with DOX alone. Significant enhancement of DOX cytotoxicity was achieved already with 0.5 µM ORC. DOX together with ORC was able to kill about 55% cells more than DOX alone. ORC significantly increases DOX efficacy in MCF7 cells probably due to the inhibition of DOX reductases. |
| | |
Authors:
|
V Hanusová; V Králová; L Schröterová; L Trilecová; A Pakostová; L Skálová |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Xenobiotica; the fate of foreign compounds in biological systems Volume: 40 ISSN: 1366-5928 ISO Abbreviation: Xenobiotica Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-09-14 Completed Date: 2011-01-04 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 1306665 Medline TA: Xenobiotica Country: England |
Other Details:
|
Languages: eng Pagination: 681-90 Citation Subset: IM |
Affiliation:
|
Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antibiotics, Antineoplastic
/
metabolism,
pharmacology* Caspases / metabolism Cell Line, Tumor Doxorubicin / metabolism, pharmacology* Electric Impedance Ethanolamines / pharmacology* Humans Isoquinolines / pharmacology* Oxidoreductases / antagonists & inhibitors*, metabolism |
| Chemical | |
Reg. No./Substance:
|
0/Antibiotics, Antineoplastic; 0/Ethanolamines; 0/Isoquinolines; 148317-76-4/oracine; 23214-92-8/Doxorubicin; EC 1.-/Oxidoreductases; EC 3.4.22.-/Caspases |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Human adipose-derived stromal cells stimulate autogenous skeletal repair via paracrine Hedgehog sign...
Next Document: The Association Between Symptomatic Asthma and Neurobehavioral Comorbidities Among Children.